{
    "nctId": "NCT00960154",
    "briefTitle": "PEAK PlasmaBlade\u2122 4.0 Versus Traditional Electrosurgery in Lumpectomy",
    "officialTitle": "A Prospective, Randomized, Controlled Study to Evaluate Use of the PEAK PlasmaBladeTM 4.0 in Breast Lumpectomy",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Histological Metrics: Amount of Overlying Adherent Char on Slide; Damage to Tumor Epithelium; Effect of Electrosurgical Damage on Diagnostic Quality of Lumpectomy Specimen",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Age between 18 and 90 years old\n2. Physically healthy, stable weight\n3. Requiring lumpectomy with wire localization for suspected or confirmed malignant breast disease.\n4. Subject must understand the nature of the procedure and provide written informed consent prior to the procedure.\n5. Subject must be willing and able to comply with all follow-up evaluations\n\nExclusion Criteria:\n\n1. Age younger than 18 or greater than 90 years old\n2. Infection (local or systemic)\n3. Cognitive impairment or mental illness\n4. Severe cardiopulmonary deficiencies\n5. Unable to follow instructions or complete follow-up\n6. Currently taking any medication known to affect healing\n7. Currently enrolled in another investigational device or drug trial",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}